MIR6851

Across TCGA pan-cancer cohorts, MIR6851 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated MIR6851 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher MIR6851 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR6851 expression acts as an unfavorable survival marker, although some lineages such as THYM show a favorable association.

ACC, TGCT, and THCA are the cancer types where MIR6851 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	IV	0.010	0.383	<.001	54	view →
TGCT	OS	Tertile	III,IV	0.501	1.000	.014	36	view →
THCA	OS	Tertile	IV	0.729	1.000	<.001	33	view →
PRAD	DFS	Tertile	All	0.869	0.944	<.001	30	view →
MESO	OS	Tertile	All	0.152	0.583	.004	27	view →
ESCA	OS	Median	IV	0.222	0.698	.006	24	view →
COAD	DFS	Tertile	All	0.709	0.800	.010	21	view →
DLBC	DFS	Tertile	II,III,IV	0.416	0.878	.021	18	view →
OV	OS	Tertile	III,IV	0.772	0.867	.008	18	view →
SKCM	DFS	Tertile	All	0.094	0.247	.018	6	view →
BRCA	DFS	Tertile	III,IV	0.646	0.806	.046	3	view →
THYM	DFS	Tertile	All	1.000	0.719	.045	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

MIR6851–ACC (DFS)

Open the ACC breakdown →